Purple Biotech Ltd (PPBT)

Purple Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.52	14.49	15.03	10.89	11.25	4.39
Short-Term Investments	0.87	0.92	17.08	36.31	46.56	0.01
Cash & Short-Term Investments	7.39	15.41	32.11	47.2	57.81	4.4
Cash Growth	-59.83%	-52.01%	-31.96%	-18.35%	1215.24%	-34.25%
Accounts Receivable	-	-	-	-	0.5	-
Other Receivables	-	-	-	-	-	1.49
Receivables	-	-	-	-	0.5	3.49
Prepaid Expenses	-	0.21	1	1.01	0.78	0.23
Other Current Assets	0.47	0.17	0.15	0.27	0.2	0.18
Total Current Assets	7.86	15.79	33.26	48.47	59.28	8.3
Property, Plant & Equipment	0.36	0.47	0.68	0.9	0.97	0.24
Long-Term Investments	-	-	-	0.19	-	-
Other Intangible Assets	27.84	28.04	20.68	20.48	20.48	6.17
Other Long-Term Assets	-	-	-	0.16	3.07	-
Total Assets	36.07	44.3	54.62	70.2	83.8	14.72
Accounts Payable	3.04	3.53	2.13	1.47	1.2	1.25
Accrued Expenses	2.15	3.46	4.72	2.56	1.69	1.15
Current Portion of Leases	0.18	0.19	0.19	0.2	0.21	0.2
Current Unearned Revenue	-	-	-	-	-	0.96
Other Current Liabilities	1.1	-	0.01	0.02	-	-
Total Current Liabilities	6.47	7.18	7.06	4.25	3.1	3.55
Long-Term Leases	0.08	0.16	0.32	0.55	0.69	0.03
Other Long-Term Liabilities	-	2.52	-	-	-	-
Total Liabilities	6.69	10.01	7.52	5.09	4.05	3.86
Additional Paid-In Capital	135.6	133.18	126.41	123.95	118.91	46.99
Retained Earnings	-143.62	-137.45	-117.57	-95.91	-77.52	-49.52
Comprehensive Income & Other	37.34	38.48	38.08	36.78	38	12.96
Total Common Equity	29.32	34.21	46.91	64.83	79.39	10.42
Minority Interest	0.06	0.09	0.19	0.28	0.36	0.44
Shareholders' Equity	29.38	34.3	47.1	65.11	79.75	10.86
Total Liabilities & Equity	36.07	44.3	54.62	70.2	83.8	14.72
Total Debt	0.26	0.35	0.52	0.75	0.9	0.22
Net Cash (Debt)	7.13	15.06	31.6	46.45	56.91	4.17
Net Cash Growth	-60.34%	-52.34%	-31.98%	-18.38%	1264.09%	-37.58%
Net Cash Per Share	0.03	0.07	0.17	0.26	0.49	0.22
Filing Date Shares Outstanding	275.32	265.58	207.87	178.26	175.11	40.46
Total Common Shares Outstanding	275.32	252.38	184.82	178	172.11	19.56
Working Capital	1.4	8.61	26.2	44.22	56.18	4.76
Book Value Per Share	0.11	0.14	0.25	0.36	0.46	0.53
Tangible Book Value	1.47	6.16	26.23	44.35	58.91	4.25
Tangible Book Value Per Share	0.01	0.02	0.14	0.25	0.34	0.22

Source: S&P Capital IQ. Standard template. Financial Sources.